The Indian Council of Medical Research (ICMR) is India's premier institution for biomedical research, operating as an autonomous body under the Department of Health Research, Ministry of Health and Family Welfare, Government of India. Its origin dates back to 1911, when it was established as the Indian Research Fund Association (IRFA) with the specific objective of sponsoring and coordinating medical research in the country. The IRFA was renamed the ICMR in 1949 to reflect its considerably expanded scope and focus on addressing the nation's evolving health challenges after independence.
The ICMR's mechanism involves formulating, coordinating, and promoting biomedical research, with its priorities aligned with national health objectives like controlling communicable diseases, addressing nutritional disorders, and investigating non-communicable diseases. It conducts research through two main channels: intramural research within its network of over 27 permanent institutes and centers, and extramural research by providing grants-in-aid to scientists outside ICMR institutions. The council also develops and disseminates guidelines and regulations, such as the National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, and hosts the Clinical Trials Registry - India (CTRI), established in 2007.
The ICMR connects to other key institutions like the Council of Scientific and Industrial Research (CSIR) and the National Centre for Disease Control (NCDC) in the broader Indian science and health ecosystem. Recently, the ICMR has undergone significant changes, including a strategic shift to a mission-oriented ecosystem and the restructuring of its institutional architecture. In 2026, it introduced the Single Ethics Review (SER) model to streamline ethics approvals for multi-centre clinical research, replacing the need for each institution to conduct an independent review. Furthermore, a new mandate was issued in 2026 to prioritize clinical trials based on Indian body types and lifestyles, moving away from sole reliance on Western data to generate homegrown evidence for effective and affordable therapies. This has also involved renaming and repurposing institutes, such as the National Institute for Research in Reproductive and Child Health in Mumbai, which was renamed the National Institute for Research on Women's Health.